Davis Sara L M
Visiting scholar at New York University's Center for Human Rights and Global Justice, New York, USA, and was Senior Human Rights Advisor at the Global Fund to Fight AIDS, Tuberculosis and Malaria from January 2013 to May 2015.
Health Hum Rights. 2015 Dec 10;17(2):97-110.
In response to new scientific developments, UNAIDS, WHO, and global health financing institutions have joined together to promote a "fast-track" global scale-up of testing and treatment programs. They have set ambitious targets toward the goal of ending the three diseases by 2030. These numerical indicators, based on infectious disease modeling, can assist in measuring countries' progressive realization of the right to health. However, they only nominally reference the catastrophic impact that human rights abuses have on access to health services; they also do not measure the positive impact provided by law reform, legal aid, and other health-related human rights programs. Drawing on experience at the Global Fund to Fight AIDS, Tuberculosis and Malaria, which has incorporated expanded stakeholder consultation and human rights programming into its grants, the article argues that addressing human rights barriers to access is often an ad hoc activity occurring on the sidelines of a health grantmaking process that has focused on the scale-up of biomedical programs to meet global health indicators. To ensure that these biomedical programs have impact, UN agencies and health financing mechanisms must begin to more systematically and proactively integrate human rights policy and practice into their modeling and measurement tools.
为应对新的科学发展，联合国艾滋病规划署、世界卫生组织和全球卫生融资机构联合起来，推动在全球范围内“快速扩大”检测和治疗项目。他们为在2030年终结这三种疾病的目标设定了宏伟的指标。这些基于传染病模型的数值指标，有助于衡量各国在逐步实现健康权方面的进展。然而，它们只是名义上提及了侵犯人权行为对获得卫生服务的灾难性影响；它们也没有衡量法律改革、法律援助及其他与健康相关的人权项目所带来的积极影响。借鉴全球抗击艾滋病、结核病和疟疾基金的经验（该基金已将扩大利益相关方协商和人权项目纳入其赠款项目），本文认为，解决获得卫生服务方面的人权障碍往往是一项临时活动，发生在以扩大生物医学项目规模以实现全球卫生指标为重点的卫生拨款过程之外。为确保这些生物医学项目产生影响，联合国机构和卫生融资机制必须开始更系统、更积极地将人权政策和实践纳入其模型和测量工具中。
